Endo Pharmaceuticals (ENDP) announced it will acquire Indevus Pharmaceuticals, Inc. (IDEV) for approx. $370 million, or $4.50 per share in cash, and up to an additional $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Advertisement
- Hugo. .. …while extreme capitalism does not hesitate to lie (no explicit bibliographic...
- Dan Allen .. If only the lazy Germans would stop taking from hard working Americans, then...
- Aspen .. Apology accepted. :) The pleasure was all mine.
- CMCJ .. Well, one more step towards the end of the U.S.A. The country says no, so we get it...
- Karl Marx .. Yes, the southern europeans are paid more than they are worth. The exchange rate...
- Zhuubaajie .. There is a never-published school of conspiracy economics that goes as follows: 1....
- Jan .. @Karl Marx It is not ants and grasshoppers but just macroeconomic imbalances that caused...
- Lionel A .. skorrent says ‘It absorbs it so well that the first 50 ppm in the atmosphere...
